The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Giuseppe Cardaci
Employment - GenesisCare
Stock and Other Ownership Interests - Clarity Pharmaceuticals; CSL Behring; Telix Pharmaceuticals
Honoraria - Oncobeta
Research Funding - GenesisCare
Travel, Accommodations, Expenses - Oncobeta
 
Aviral Singh
Employment - GenesisCare Australia Pty Ltd
Stock and Other Ownership Interests - GenesisCare Australia Pty Ltd
Research Funding - 3BP Pharma; Radiopharm Theranostics; Telix International Pharmaceuticals; Telix Pharmaceuticals
 
Howard Gurney
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; Merck Serono; Merck Sharp & Dohme; Pfizer; Roche
Speakers' Bureau - Astellas Pharma; AstraZeneca; Ipsen; Merck Serono
 
Alison Zhang
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol Myer Squibb; Ferring; Johnson & Johnson/Janssen; Merck; MSD Oncology; Pfizer (Inst)
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Janssen Oncology; Merck; Merck Sharp & Dohme; Pfizer
Research Funding - Astellas Pharma (Inst); Bayer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; MSD Oncology
 
Jeffrey Wong
Research Funding - Accuray (Inst); Accuray (Inst); Varian Medical Systems (Inst)
Travel, Accommodations, Expenses - Accuray
 
Tanya Dorff
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; Bayer; Janssen Oncology; Novartis; Pfizer
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Hookipa Biotech (Inst); Janssen Oncology (Inst); Promontory Therapeutics (Inst)
 
Shyam Srinivas
No Relationships to Disclose
 
Amanda Macaraeg
Employment - UC Irvine Medical Center
 
Hong Song
Consulting or Advisory Role - Cellsight Technologies; Lanth; Lanth
Research Funding - Clarity Pharmaceuticals (Inst)
 
Sandy Srinivas
Consulting or Advisory Role - Eisai; Janssen Oncology; Novartis; Seagen
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Genentech (Inst); Merck (Inst); Seattle Genetics/Astellas (Inst)
Other Relationship - Pfizer
 
Yüksel Ürün
Honoraria - Abdi Ibrahim; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eczacibasi; Gen Ilaç; Gilead Sciences; Janssen; Merck Serono; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - Abdi Ibrahim; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eczacibasi; Gen Ilaç; Gilead Sciences; Janssen; Merck Serono; MSD; Novartis; Pfizer; Roche
Speakers' Bureau - Abdi Ibrahim; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eczacibasi; Gen Ilaç; Janssen; Merck Serono; MSD; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Abdi Ibrahim; Bristol-Myers Squibb; Eczacibasi; Gen Ilaç; Pfizer; Roche
 
Ozlem Kucuk
No Relationships to Disclose
 
Robert Dreicer
Consulting or Advisory Role - Astellas Pharma; LNC Pharma; Merck; Pfizer; Urogen pharma
Research Funding - Exelixis (Inst)
 
Pedro Barata
Stock and Other Ownership Interests - Luminate Medical
Honoraria - Medscape; UroToday
Consulting or Advisory Role - Astellas Medivation; AstraZeneca; AVEO; Bayer; BMS; Caris Life Sciences; Dendreon (Inst); Eisai; EMD Serono; Exelixis; Ipson; Merck; Novartis; Pfizer
Speakers' Bureau - Astellas Pharma; AstraZeneca
Research Funding - AVEO (Inst); Blue Earth Diagnostics (Inst); Exelixis; Merck (Inst); Pfizer (Inst)
 
Alton Sartor
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie; Abdera Thereapeutics; Actithera; Advancell; Advancell; ARTbio; Asta; Azurna; BioNTech SE; Cardinal Health; Clarity Pharmaceuticals; Convergent Therapeutics; Curadh; Curadh; Lilly; NVision; Ratiopharm; Telix Pharmaceuticals; United Health Group
Honoraria - Actinium Pharmaceuticals; Advancell; AstraZeneca; Clarity Pharmaceuticals; Convergent Therapeutics; Intellisphere; Lantheus Medical Imaging; Pfizer; Point Therapeutics; Ratiopharm; Sanofi; Telix Pharmaceuticals
Consulting or Advisory Role - Abdera Thereapeutics; Actinium Pharmaceuticals; Actithera; Advancell; Alpha9; Amgen; ARTbio; Astellas Pharma; AstraZeneca; Bayer; Clarity Pharmaceuticals; Convergent Therapeutics; Curdah; Curium Pharma; Full Life; Fusion Pharmaceuticals; Isotopen Technologien; Janssen; Johnson & Johnson/Janssen; Lantheus Medical Imaging; Merck; Modex; Norroy; NorthStar; Novartis; Nucleus Radiopharma; NVision; Pfizer; Point Biopharma; Precede Bio; Progenics; Ratiopharm; Sanofi; Swiss Rockets; Syneos Health; Telix Pharmaceuticals; Telix Pharmaceuticals; Wren Laboratories; X-Cancer Software
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Janssen; Lantheus Medical Imaging (Inst); Novartis (Inst)
Expert Testimony - Sanofi
Travel, Accommodations, Expenses - Bayer; Lantheus Medical Imaging; Sanofi
 
Stanley Ngai
Travel, Accommodations, Expenses - Advancell
 
Anne Robert
Employment - Full-Life Technologies GmbH
Stock and Other Ownership Interests - Novartis
Travel, Accommodations, Expenses - Full-Life Technologies GmbH
 
Denis Ferreira
Employment - Full-Life; RayzeBio
Stock and Other Ownership Interests - Bayer; BMSi; Lilly; Medtronic; Novartis; Novo Nordisk
 
Debora Barton
Employment - Advanced Accelerator Applications; Carisma Therapeutics; Full-Life Technologies; Iovance Biotherapeutics; TScan Therapeutics
Leadership - Arovella Therapeutics; NKILT Therapeutics
Stock and Other Ownership Interests - Advanced Accelerator Applications; Arovella Therapeutics; Carisma Therapeutics; Full-Life Technologies; Iovance Biotherapeutics; NKILT Therapeutics; TScan Therapeutics
 
Aaron Hansen
Consulting or Advisory Role - Bayer; Full-Life technology; Janssen; Merck
Speakers' Bureau - Astellas Scientific and Medical Affairs Inc; Janssen; MSD Oncology
Research Funding - Advancell (Inst); AVEO (Inst); Bristol-Myers Squibb (Inst); Full-Life Technologies (Inst); Fusion Pharmaceuticals (Inst); Janssen (Inst); Macrogenics (Inst); Merck (Inst); Roche/Genentech (Inst); Seagen (Inst); Tyra Biosciences (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer